We take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...

All doses of Novo Nordisk’s blockbuster diabetes and obesity drugs were listed as available on the FDA shortage list as of ...

Pharmaceutical management expert Kenneth Getz shares insights on broader trends in the pharma sector influencing the recent wave of layoffs.

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

Verona Pharma (Nasdaq: VRNA) is already recording millions of dollars in revenue after launching its lead drug in August ...

Canaccord lowered the firm’s price target on Ocuphire Pharma (OCUP) to $10 from $18 and keeps a Buy rating on the shares. The firm noted ...

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ ... in and hosting two webinars that are open to the public during October. Lantern expects to discuss in detail how big data and AI are ...